Try our Advanced Search for more refined results
July 03, 2013
Astrazeneca AB v. Hanmi USA, Inc.
Case Number:
13-1490
Court:
Nature of Suit:
830 Patent Infringement (Fed. Question)
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
February 26, 2014
Fed. Circ. Won't Rehear IP Suit Over Hanmi's Nexium Generic
The Federal Circuit on Tuesday refused AstraZeneca AB's request for an en banc rehearing of its patent dispute over Hanmi Pharmaceutical Co. Ltd.'s generic version of AstraZeneca's acid reflux drug Nexium, stymying AstraZeneca's efforts to block the generic.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login